Jul 20, 2026 · Newsday
Clinical AI on Trial: Shadow Tools and Governance Gaps | Newsday with Yaw Fellin and Matt Troup July 20, 2026: A new Nature of Medicine study claims general-purpose LLMs outperform specialized clinical AI, but is that the right benchmark to begin with? Bill and Drex are joined by Yaw Fellin , General Manager of UpToDate at Wolters Kluwer , and Matt Troup , Clinical Strategy Principal at Abridge , to break down what those benchmarks actually measure, why shadow AI is already spreading through health systems, and what "clinical grade" really means. Plus: the first-ever look at UpToDate's new drug dosing feature in Expert AI, and why automaticity bias may be the next liability crisis hiding in plain sight. Key Points: 03:18 Nature Study Breakdown 10:25 Shadow AI Reality Check 18:37 Transparency and Provenance 23:40 Human in the Loop Wrap Keep up to date on the latest in health IT: https://thisweekhealth.com/news/ X : This Week Health LinkedIn: This Week Health Donate: Alex’s Lemonade Stand: Foundation for Childhood Cancer